Genomic Insights into Short Stature in Children Born Small for Gestational Age: A Korean Multicenter Exome Study
Yena Lee1, Hwal Rim Jeong2, Eun Young Kim3
1Department of Pediatrics, Hallym University Sacred Heart Hospital, Anyang 14068, Republic of Korea.
Insights
Genetic testing identified causes in 17.8% of children with small for gestational age (SGA) short stature (SGA-SS). Copy number variants (CNVs) and single-nucleotide variants (SNVs) were key findings, aiding diagnosis in those with developmental delays.
Area of Science:
- Genetics
- Pediatrics
- Endocrinology
Background:
- 10-15% of infants born small for gestational age (SGA) remain short due to unknown growth failure.
- Investigating genetic causes of SGA with short stature (SGA-SS) is crucial.
Purpose of the Study:
- To investigate the genetic causes of SGA with short stature (SGA-SS) resulting from failed catch-up growth.
- To determine the diagnostic yield of whole-exome sequencing in SGA-SS.
Main Methods:
- Whole-exome sequencing was performed on 191 children from SGA-SS cohorts.
- Copy number variants (CNVs) were confirmed using chromosomal microarray analysis.
Main Results:
- Genetic variants were identified in 34 children (17.8% diagnostic rate).
- CNVs (50%) included 22q11.2 microdeletion syndrome; single-nucleotide variants (SNVs) (50%) included mutations in genes like SLC26A2, COL2A1, and CDKN1C.
- Genetic causes were found in 58.3% of patients with intellectual disability/developmental delay (ID/DD).
Conclusions:
- SGA-SS has a heterogeneous genetic basis, with CNVs playing a significant role.
- The study highlights the relevance of 22q11.2 microdeletion syndrome and supports genetic testing for familial cases or those with ID/DD.
Context:
Most infants born small for gestational age (SGA) experience catch-up growth within 2 years, while 10% to 15% remain short. The cause of this persistent growth failure remains unknown.
Objective:
To investigate the genetic causes of SGA with short stature (SGA-SS) due to failure of catch-up growth.
Methods:
A total of 191 children from multicenter SGA-SS cohorts across 7 hospitals in South Korea underwent whole-exome sequencing. Identified copy number variants (CNVs) were confirmed via chromosomal microarray analysis.
Results:
Genetic variants were identified in 34 children (17.8% diagnostic rate). CNVs accounted for 50% (17/34), including 6 children with 22q11.2 microdeletion syndrome, predominantly exhibiting mild dysmorphic features without severe intellectual disability (ID), developmental delay (DD) or severe anomalies. Single-nucleotide variants (SNVs) were identified in 17 children (17/34, 50%). One had compound heterozygous mutations in SLC26A2, 1 likely pathogenic mutation, and another of uncertain significance. The remaining children had heterozygous variants, including 5 pathogenic variants in COL2A1, ACAN, SALL1, TAOK1, ANKRD11 and 11 likely pathogenic variants in PIK3R1, PLAG1, SCUBE3, COL9A2 (in 2 patients), SMAD4, PTPN11 (in 2 patients), CDKN1C, ACAN, NF1. A novel familial Silver-Russell syndrome case was linked to a CDKN1C mutation. Genetic causes were identified in 14 (58.3%) of 24 patients with ID/DD: 9 with CNVs and 5 with SNVs.
Conclusion:
SGA-SS has a heterogeneous genetic basis, with CNVs significantly contributing. The variable presentation of 22q11.2 microdeletion syndrome highlights its relevance. A genetic diagnosis is more likely in familial cases or those with ID/DD, supporting the utility of genetic testing.
Related Concept Videos
Nature and Nurture
Polygenic Traits
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genome Size and the Evolution of New Genes
Genome Size and the Evolution of New Genes
Gene-Environment Interactions


